Not applicableStudy completedNCT02827227
What this trial is testing
Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)
Who this might be right for
HIV-infected Patients
Hospices Civils de Lyon 99